Acronyms | Used for |
5 + 2 | Leukemia, acute myeloid (induction) |
7 + 3 | Leukemia, acute myeloid (induction) |
8 in 1 | Brain tumors
Retinoblastoma |
AAV (DD) | Wilms tumor |
ABVD | Lymphoma, Hodgkin Disease |
AC | Breast cancer |
ACAV (J) | Wilms tumor |
AP | Endometrial cancer |
AVD | Wilms tumor |
AVDP | Leukemia, acute lymphocytic (relapse) |
AV (EE) | Wilms tumor |
AV (K) | Wilms tumor |
AV (L) | Wilms tumor |
AV (Wilms Tumor) | Wilms tumor |
BACOP | Lymphoma, non-Hodgkin |
BEP | Ovarian cancer; testicular cancer |
BL | Prostate cancer |
BOLD | Melanoma |
CA | Leukemia, acute myeloid (induction) |
CAF | Breast cancer |
CAP | Bladder cancer |
Carbo-Tax | Adenocarcinoma, unknown primary
Nonsmall cell lung cancer
Ovarian cancer |
CAVE | Small cell lung cancer |
CAV-P/VP | Neuroblastomas |
CC | Ovarian cancer |
CCCDE | Retinoblastoma |
CCDDT | Neuroblastomas |
CCDLMV | Lymphoma, non-Hodgkin (Burkitt) |
CCDT | Melanoma |
CCT | Neuroblastomas |
CDDP/VP-16 | Brain tumors |
CDDP + VP-16 | Neuroblastomas |
CDLPV | Leukemia, acute lymphocytic (induction) |
CD | Rhabdomyosarcoma |
CE | Neuroblastomas
Retinoblastoma
Wilms tumor |
CE-CAdO | Neuroblastomas |
CEV | Rhabdomyosarcoma |
CF | Head and neck cancer |
CFM | Breast cancer |
CHL + PRED | Leukemia, chronic lymphocytic |
CHOP | Lymphoma, non-Hodgkin |
CHOP-Bleo | Lymphoma, non-Hodgkin |
CI | Neuroblastomas |
CISCA | Bladder cancer |
CMF | Breast cancer |
CMV | Bladder cancer |
CNOP | Lymphoma, non-Hodgkin |
CO | Retinoblastoma |
COMLA | Lymphoma, non-Hodgkin |
COP | Lymphoma, non-Hodgkin |
COP-BLAM | Lymphoma, non-Hodgkin |
COPP | Lymphoma, non-Hodgkin |
CP | Ovarian cancer |
CT | Ovarian cancer |
CV | Retinoblastoma |
CVD | Melanoma |
CVP | Lymphoma, non-Hodgkin; leukemia, chronic lymphocytic |
CYVADIC | Sarcoma |
DA | Leukemia, acute myeloid (induction) |
Dartmouth Regimen | Melanoma |
DAT | Leukemia, acute myeloid (induction) |
DAV | Leukemia, acute myeloid (induction) |
DDV | Wilms tumor |
DHAP | Lymphoma, non-Hodgkin |
DMC | Gestational trophoblastic cancer |
EAP | Gastric cancer |
EC | Small cell lung cancer |
EDAP | Multiple myeloma |
EE | Wilms tumor |
EE-4A | Wilms tumor |
ELF | Gastric cancer |
EMA/CO | Gestational trophoblastic disease |
EP | Adenocarcinoma, unknown primary
Small cell lung cancer
Testicular cancer |
EP/EMA | Gestational trophoblastic tumor |
EPOCH | Lymphoma, non-Hodgkin |
EP/PE | Nonsmall cell lung cancer |
ESHAP | Lymphoma, non-Hodgkin |
EV | Prostate cancer |
EVA | Lymphoma, Hodgkin disease |
FAC | Breast cancer |
FAM | Gastric cancer
Pancreatic cancer |
FAMTX | Gastric cancer |
FL | Prostate cancer |
FLe | Colorectal cancer |
FU HURT | Head and neck cancer |
FU/Leucovorin | Colorectal cancer |
FZ | Prostate cancer |
GC | Nonsmall cell lung cancer |
Gemcitabine-Cis | Nonsmall cell lung cancer |
HDMTX | Osteosarcoma
Sarcoma |
HI-CDAZE | Leukemia, acute myeloid (induction) |
HIPE-IVAD | Neuroblastomas |
ICE | Osteosarcoma; soft tissue sarcoma |
IDMTX/MP | Leukemia, acute lymphocytic (consolidation) |
IE | Soft tissue sarcoma |
IL-2 + IFN | Melanoma |
IMVP-16 | Lymphoma, non-Hodgkin |
M-2 | Multiple myeloma |
MACOP-B | Lymphoma, non-Hodgkin |
MAID | Soft tissue sarcoma |
m-BACOD | Lymphoma, non-Hodgkin |
MINE | Lymphoma, non-Hodgkin |
MINE-ESHAP | Lymphoma, non-Hodgkin |
MM | Leukemia, acute lymphoblastic (maintenance) |
MOPP | Lymphoma, Hodgkin disease |
MOPP/ABV Hybrid | Lymphoma, Hodgkin disease |
MP | Multiple myeloma |
MTX-CDDPAdr | Osteosarcoma |
MTX/MP | Leukemia, acute lymphocytic (maintenance) |
MTX/MP/VP | Leukemia, acute lymphocytic (maintenance) |
MV | Leukemia, acute myeloid (induction) |
MVAC | Bladder |
MVPP | Lymphoma, Hodgkin disease |
N4SE Protocol | Neuroblastomas |
N6 Protocol | Neuroblastomas |
NFL | Breast cancer |
OPEC | Neuroblastomas |
OPEC-D | Neuroblastomas |
PAC (CAP) | Ovarian cancer |
PC | Bladder cancer
Nonsmall cell lung cancer |
PCV | Brain tumors |
PE | Prostate cancer |
PE-CAdO | Neuroblastomas |
PFL | Colorectal cancer
Head and neck cancer |
PFL + IFN | Head and neck cancer |
POC | Brain tumors |
Pro-MACE | Lymphoma, non-Hodgkin |
Pro-MACE-CytaBOM | Lymphoma, non-Hodgkin |
Pt-FU | Head and neck cancer |
PV | Breast cancer |
PVD | Leukemia, acute lymphocytic (induction) |
PVDA | Leukemia, acute lymphocytic (induction) |
R-CHOP | CHOP-Rituximab |
Regimen A1 | Neuroblastomas |
Regimen A2 | Neuroblastomas |
Saltz Regimen | Colorectal cancer |
Sequential Dox-CMF | Breast cancer |
Stanford V | Lymphoma, Hodgkin disease |
TIP | Head and neck cancer |
VAB VI | Testicular cancer |
VAC | Ovarian cancer
Retinoblastoma
Rhabdomyosarcoma |
VAC Pulse | Rhabdomyosarcoma |
VAD | Multiple myeloma |
VATH | Breast cancer |
VBAP | Multiple myeloma |
VBMCP | Multiple myeloma |
VBP | Testicular cancer |
VC | Nonsmall cell lung cancer |
VCAP | Multiple myeloma |
Vinorelbine-Cis | Nonsmall cell lung cancer |
VIP | Testicular |
VP | Leukemia, acute lymphoblastic (induction) |